Prevalence of BRCA in Patients With Ovarian Cancer

NCT02222883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2021-06-16

No results posted yet for this study

Summary

The aim of this prospective registration and translational research study is to evaluate the praevalence of BRCA regarding germline and somatic mutations.

Conditions

Interventions

GENETIC

Testing of BRCA status regarding germline and somatic mutation

Sponsors & Collaborators

  • AGO Research GmbH

    lead INDUSTRY

Principal Investigators

  • Philipp Harter, PhD MD · Kliniken Essen-Mitte, Germany

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222883 on ClinicalTrials.gov